Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | CRHBP | P24387 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dioxane SCHEMBL9698192 | 1.00 | — | — | |
| SCHEMBL78595 | 1.00 | TTR (1.00) | TTRALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL6057268 | 1.00 | TTR (1.00) | TTRALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL3137720 | 1.00 | TTR (1.00) | TTRALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1119 | 1.00 | TTR (1.00) | TTRALDH1A1TSHRMEN1KMT2A | |
| Dioxane SCHEMBL3631647 | 1.00 | TTR (1.00) | TTRALDH1A1TSHRMEN1KMT2A | |
| Dioxane SCHEMBL9836999 | 1.00 | — | — | |
| SCHEMBL16041435 | 1.00 | TTR (1.00) | TTRALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL3137753 | 1.00 | TTR (1.00) | TTRALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL11334265 | 1.00 | TTR (1.00) | TTRALDH1A1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9533071-B2 | Wound healing compositions including cyanoacrylate monomers and phenytoin | ADHEZION BIOMEDICAL, LLC (US) | 2017-01-03 | — | — | US | disclosed |
| US-9421297-B2 | Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides | ADHEZION BIOMEDICAL, LLC (US) | 2016-08-23 | — | — | US | disclosed |
| US-20150320905-A1 | WOUND HEALING COMPOSITIONS INCLUDING CYANOACRYLATE MONOMERS AND PHENYTOIN | H.B. FULLER MEDICAL ADHESIVE TECHNOLOGIES, LLC. | 2015-11-12 | — | — | US | disclosed |
| US-20150283290-A1 | STERILIZED COMPOSITIONS OF CYANOACRYLATE MONOMERS AND NAPHTHOQUINONE 2,3-OXIDES | ADHEZION BIOMEDICAL, LLC (US) | 2015-10-08 | — | — | US | disclosed |
| US-9101683-B2 | Wound healing compositions including cyanoacrylate monomers and phenytoin | ADHEZION BIOMEDICAL, LLC (US) | 2015-08-11 | — | — | US | disclosed |
| US-20150071869-A1 | WOUND HEALING COMPOSITIONS INCLUDING CYANOACRYLATE MONOMERS AND PHENYTOIN | H.B. FULLER MEDICAL ADHESIVE TECHNOLOGIES, LLC. | 2015-03-12 | — | — | US | disclosed |
| US-8894986-B2 | Wound healing compositions including cyanoacrylate monomers and phenytoin | ADHEZION BIOMEDICAL, LLC (US) | 2014-11-25 | — | — | US | disclosed |
| US-20130136715-A1 | WOUND HEALING COMPOSITIONS BASED ON CYANOACRYLATES AND 5,5-DISUBSTITUTEDHYDANTOINS, INCLUDING PHENYTOIN | ADHEZION BIOMEDICAL, LLC (US) | 2013-05-30 | — | — | US | disclosed |
| US-8287901-B2 | Wound healing compositions based on cyanoacrylates and 5,5-disubstitutedhydantoins, including phenytoin | ADHEZION BIOMEDICAL, LLC (US) | 2012-10-16 | — | — | US | disclosed |
| EP-0013008-B1 | PROCESS FOR PRODUCING ALCOHOLS | UNION CARBIDE CORPORATION (US) | 1983-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150071869-A1 | WOUND HEALING COMPOSITIONS INCLUDING CYANOACRYLATE MONOMERS AND PHENYTOIN | DSC1, COL14A1, GAP43 | TTR 475/4885ALDH1A1 259/4885TSHR 4862/4885 |
| US-20130136715-A1 | WOUND HEALING COMPOSITIONS BASED ON CYANOACRYLATES AND 5,5-DISUBSTITUTEDHYDANTOINS, INCLUDING PHENYTOIN | DSC1, DACH1, PLOD1 | TTR 585/4885ALDH1A1 285/4885TSHR 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.